Table 2.

Difference in dose between adapted plan and current practice represented by the scheduled plan, (scaled to 50.4 Gy/28 fractions). * highlights significant p-values. SD; standard deviation, CTV; clinical target volume, PTV; planning target volume, LFH; left femoral head, RFH; right femoral head.

Structure	Dosimetric Parameter [units]	p-value	Difference (Adapted – Scheduled plan)
			Mean	Range	SD
CTV	Dmax [%]	0.04*	−0.7	−2.5 to 0.4	0.9
	Dmin [%]	0.004*	6	−0.8 to 24.6	7.1
	Dmean [%]	0.17	0.4	−1.5 to 1.6	0.9
Bladder	V100% [cc]	0.18	−4.8	−30.4 to 0.7	9.6
	Dmean [Gy]	0.01*	−1.3	−2.5 to 0.4	0.4
Bowel	V100% [cc]	0.7	−7	−65.6 to 2.0	20.7
	Dmean [Gy]	0.58	0.2	−2.0 to 2.4	0.4
Rectum	V100% [cc]	0.26	−0.5	−3.7 to 2.5	1.6
	D50% [Gy]	0.14	1.4	−0.6 to 6.1	0.8
LFH	D15% [Gy]	0.02*	−1.5	−3.1 to 1.7	0.5
RFH	D15% [Gy]	0.02*	−1.6	−4.2 to 1.5	0.5
Bone Marrow	Dmean [Gy]	0.049*	−0.4	−0.9 to 0.5	0.2
Body-PTV	V50% [cc]	0.11	−194.6	−1066.7 to 198.6	359.7
Bowel Bag	V100% [cc]	0.7	−7.2	146.2 to 42.6	52.1
	Dmean [Gy]	0.63	0.2	−1.9 to 2.5	0.4